* JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 25/02 | 8,97% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 25/02 | 8,59% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 25/02 | 8,73% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 25/02 | 8,85% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 25/02 | 9,00% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 25/02 | 8,76% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 25/02 | 8,83% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 25/02 | 9,08% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 25/02 | 9,31% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 25/02 | 9,07% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 25/02 | 7,57% |
| **** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 25/02 | 9,21% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 25/02 | 8,97% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | 25/02 | 9,20% |
| * JPM TOTAL EMERGING MARKETS INCOME D (DIV) EUR | 25/02 | 7,45% |
| *** JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR (HEDGED) | 25/02 | 9,52% |
| ** JPM TOTAL EMERGING MARKETS INCOME I (DIST) EUR (HEDGED) | 25/02 | 9,51% |
| **** JPM US AGGREGATE BOND A (ACC) EUR (HEDGED) | 25/02 | 0,99% |
| ** JPM US AGGREGATE BOND A (ACC) USD | 25/02 | 0,95% |
| ** JPM US AGGREGATE BOND A (DIST) USD | 25/02 | 1,02% |
